Sign in
4

Changes in Ownership

XBiotech Inc. Filed Acc 0001209191-19-060015

Options or other derivatives

  • Chief Executive Officer acquired 1,000,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SIMARD JOHN · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-12-06 Exercise or conversion : show line 1 in the form Stock Option +1,000,000 $11.12 $11,120,000 2,625,000 D
Loading xslF345X03/doc4.xml…